Latest Government Funding News

Regis Healthcare reveals a funding update amid government changes, projecting modest EBITDA growth despite a funding gap and rising wage costs.

Resolution Minerals has begun a large-scale stream sediment sampling program at its Horse Heaven project in Idaho, aiming to uncover new critical mineral targets and validate geological links with Perpetua Resources’ adjacent Stibnite Gold Project.

PainChek’s UK pilot reveals significant clinical improvements and economic benefits, positioning the digital pain assessment app for broader adoption in Scotland and beyond.

Regis Healthcare acknowledges the Australian Government’s recent announcement to increase aged care funding through higher AN-ACC prices and hotelling supplements, aimed at supporting wage rises for care workers. The company is currently assessing the financial implications of these changes.

icetana Limited reveals delays and payment uncertainties in its Baghdad Safe City project, raising questions about revenue timing and project execution.

LDR Assets Pty Ltd has initiated an off-market takeover bid for all stapled securities in the Elanor Commercial Property Fund (ECF), offering $0.70 cash per security, representing a premium over recent trading prices and net tangible asset backing. The offer opens on 11 September 2025 and is set to close on 13 October 2025.

Metals Australia Ltd reports key milestones in its Lac Carheil Graphite Project, achieving battery-grade spherical graphite purity and selecting Sept-Îles as the preferred site for its Battery Anode Material plant.

Elanor Investors Group advances its strategic alliance with Rockworth Capital Partners through a $125 million recapitalisation and Firmus acquisition, while rejecting an unsolicited takeover offer for its commercial property fund. The group also reports FY24 results highlighting stabilisation efforts amid high gearing.

1414 Degrees Ltd reported a widened net loss of $3.34 million for FY25 while advancing its thermal energy storage and hydrogen reactor technologies, supported by fresh equity and government grants.

AVADA Group Limited reported a significant net loss of $17.6 million for FY25, driven by major impairments in New Zealand and New South Wales operations amid challenging market conditions. The company completed a strategic consolidation of its Australian businesses and appointed new senior management to steer operational transformation.

Visionflex Group Limited’s FY25 results highlight a strong transition to a SaaS-driven model, with recurring revenue surging 49% to $1.9 million and total revenue up 33%. Key government and private sector contracts underpin future growth prospects.

Argenica Therapeutics reported a 34% revenue increase driven by R&D incentives but saw losses widen by 31% due to intensified clinical trial activity. The company is progressing its ARG-007 Phase 2 stroke trial and engaging with the FDA to lift a clinical hold.